US Stock · Smart-money analysis

BIIB Biogen Inc.

QUIET
Price
$206.28
1D
-0.17%
5D
-0.79%
20D
+3.71%
Conviction
52
Buy Score
66
Signal
QUIET
Phase
WATCHING
RVOL
0.6×
RSI
50.3
52w range
$127.00 – $219.72
Sector
Healthcare

BIIB (Biogen Inc.) is a US stock trading at $206.28, -0.17% on the day. mdvin's smart-money engine places it in the WATCHING operator phase, with a GRINDER accumulation style. Current conviction is 52/100 and the Buy Score is 66. The active signal is QUIET. It has ignited 2 time(s) in the last 90 sessions, paying off 20% of the time (typical run +1.2%). Reversal/trap risk is graded LOW. On fundamentals it looks richly valued (quality grade C, analyst upside +14.10%).

Fundamentals

P/E
36.6
Fwd P/E
12.4
EPS
5.63
ROE
4.6%
Valuation
RICHLY VALUED
Quality
C
Analyst upside
+14.10%
Next earnings
2026-10-29
Live deep-dive → Open chart Full screener

Snapshot updated daily; open the live deep-dive for the latest. Educational only — not investment advice.